Buscar
Mostrando ítems 1-10 de 1080
Neuroprotection in Hypoxic-Ischemic Brain Injury Targeting Glial Cells
(Bentham Science Publishers, 2017-10)
Brain injury constitutes a disabling health condition of several etiologies. One of the major causes of brain injury is hypoxia-ischemia. Until recently, pharmacological treatments were solely focused on neurons. In the ...
Neuroprotection in Synaptic Signalling During Neurological Disorders
(Frontiers Media, 2021-06)
Some of the most devastating and costly conditions in the world arise from neurological andneurodegenerative disorders. About one-third of the world's population suffers from neurologicaldiseases, including Parkinson's ...
Heptanoate is neuroprotective in vitro but triheptanoin post-treatment did not protect against middle cerebral artery occlusion in rats
(Elsevier Ireland Ltd, 2018)
© 2018 Elsevier B.V. Triheptanoin, the medium-chain triglyceride of heptanoate, has been shown to be anticonvulsant and neuroprotective in several neurological disorders. In the gastrointestinal tract, triheptanoin is ...
Neuroprotective role of hypothermia in hypoxic-ischemic brain injury: Combined therapies using estrogen
(Bentham Science Publishers, 2019)
Mitochondrial permeability transition pore as a suitable target for neuroprotective agents against alzheimer’s disease
(Bentham Science Publishers B.V., 2017)
Neuroprotection in hypoxic-ischemic brain injury targeting glial cells
(Bentham Science Publishers B.V., 2017)
Neuroprotective role of hypothermia in hypoxic-ischemic brain injury: Combined therapies using estrogen
(Bentham Science Publishers, 2018-12)
Hypoxic-ischemic brain injury is a complex network of factors, which is mainly characterized by a decrease in levels of oxygen concentration and blood flow, which lead to an inefficient supply of nutrients to the brain. ...
Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease
(Taylor and Francis Ltd, 2017)